208 related articles for article (PubMed ID: 36774408)
1. Targeting the E3 ligase NEDD4 as a novel therapeutic strategy for IGF1 signal pathway-driven gastric cancer.
Wang K; Yu Y; Wang W; Jiang Y; Li Y; Jiang X; Qiao Y; Chen L; Zhao X; Liu J; Yang A; Li J; Zhang R
Oncogene; 2023 Mar; 42(14):1072-1087. PubMed ID: 36774408
[TBL] [Abstract][Full Text] [Related]
2. The proximity-labeling technique BioID identifies sorting nexin 6 as a member of the insulin-like growth factor 1 (IGF1)-IGF1 receptor pathway.
Bareja A; Hodgkinson CP; Soderblom E; Waitt G; Dzau VJ
J Biol Chem; 2018 Apr; 293(17):6449-6459. PubMed ID: 29530981
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-dependent regulation of phospho-AKT dynamics by the ubiquitin E3 ligase, NEDD4-1, in the insulin-like growth factor-1 response.
Fan CD; Lum MA; Xu C; Black JD; Wang X
J Biol Chem; 2013 Jan; 288(3):1674-84. PubMed ID: 23195959
[TBL] [Abstract][Full Text] [Related]
4. NEDD4 ubiquitin ligase is a putative oncogene in endometrial cancer that activates IGF-1R/PI3K/Akt signaling.
Zhang Y; Goodfellow R; Li Y; Yang S; Winters CJ; Thiel KW; Leslie KK; Yang B
Gynecol Oncol; 2015 Oct; 139(1):127-33. PubMed ID: 26193427
[TBL] [Abstract][Full Text] [Related]
5. IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.
Li Z; Pan W; Shen Y; Chen Z; Zhang L; Zhang Y; Luo Q; Ying X
Cell Cycle; 2018; 17(10):1212-1219. PubMed ID: 29886785
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor (IGF) signaling requires αvβ3-IGF1-IGF type 1 receptor (IGF1R) ternary complex formation in anchorage independence, and the complex formation does not require IGF1R and Src activation.
Fujita M; Takada YK; Takada Y
J Biol Chem; 2013 Feb; 288(5):3059-69. PubMed ID: 23243309
[TBL] [Abstract][Full Text] [Related]
7. An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1R.
Fujita M; Ieguchi K; Cedano-Prieto DM; Fong A; Wilkerson C; Chen JQ; Wu M; Lo SH; Cheung AT; Wilson MD; Cardiff RD; Borowsky AD; Takada YK; Takada Y
J Biol Chem; 2013 Jul; 288(27):19593-603. PubMed ID: 23696648
[TBL] [Abstract][Full Text] [Related]
8. PHB2 promotes SHIP2 ubiquitination via the E3 ligase NEDD4 to regulate AKT signaling in gastric cancer.
Xu L; Xiang W; Yang J; Gao J; Wang X; Meng L; Ye K; Zhao XH; Zhang XD; Jin L; Ye Y
J Exp Clin Cancer Res; 2024 Jan; 43(1):17. PubMed ID: 38200519
[TBL] [Abstract][Full Text] [Related]
9. A viral insulin-like peptide inhibits IGF-1 receptor phosphorylation and regulates IGF1R gene expression.
Chrudinová M; Kirk NS; Chuard A; Venugopal H; Zhang F; Lubos M; Gelfanov V; Páníková T; Žáková L; Cutone J; Mojares M; DiMarchi R; Jiráček J; Altindis E
Mol Metab; 2024 Feb; 80():101863. PubMed ID: 38182007
[TBL] [Abstract][Full Text] [Related]
10. PTEN is a protein tyrosine phosphatase for IRS1.
Shi Y; Wang J; Chandarlapaty S; Cross J; Thompson C; Rosen N; Jiang X
Nat Struct Mol Biol; 2014 Jun; 21(6):522-7. PubMed ID: 24814346
[TBL] [Abstract][Full Text] [Related]
11. Impaired IGF1R signaling in cells expressing longevity-associated human IGF1R alleles.
Tazearslan C; Huang J; Barzilai N; Suh Y
Aging Cell; 2011 Jun; 10(3):551-4. PubMed ID: 21388493
[TBL] [Abstract][Full Text] [Related]
12. SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.
Liu J; Wan L; Liu P; Inuzuka H; Liu J; Wang Z; Wei W
Oncotarget; 2014 Feb; 5(4):1026-37. PubMed ID: 24657926
[TBL] [Abstract][Full Text] [Related]
13. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells.
Sarfstein R; Nagaraj K; LeRoith D; Werner H
Cells; 2019 Nov; 8(12):. PubMed ID: 31771180
[TBL] [Abstract][Full Text] [Related]
14. Heterodimerization of glycosylated insulin-like growth factor-1 receptors and insulin receptors in cancer cells sensitive to anti-IGF1R antibody.
Kim JG; Kang MJ; Yoon YK; Kim HP; Park J; Song SH; Han SW; Park JW; Kang GH; Kang KW; Oh DY; Im SA; Bang YJ; Yi EC; Kim TY
PLoS One; 2012; 7(3):e33322. PubMed ID: 22438913
[TBL] [Abstract][Full Text] [Related]
15. LMP1 promotes expression of insulin-like growth factor 1 (IGF1) to selectively activate IGF1 receptor and drive cell proliferation.
Tworkoski K; Raab-Traub N
J Virol; 2015 Mar; 89(5):2590-602. PubMed ID: 25520502
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells.
Li Z; Levine KM; Bahreini A; Wang P; Chu D; Park BH; Oesterreich S; Lee AV
Endocrinology; 2018 Jan; 159(1):285-296. PubMed ID: 29029116
[TBL] [Abstract][Full Text] [Related]
17. The E3 ubiquitin ligase NEDD4 mediates cell migration signaling of EGFR in lung cancer cells.
Shao G; Wang R; Sun A; Wei J; Peng K; Dai Q; Yang W; Lin Q
Mol Cancer; 2018 Feb; 17(1):24. PubMed ID: 29455656
[TBL] [Abstract][Full Text] [Related]
18. Post-transcriptional regulation of IGF1R by key microRNAs in long-lived mutant mice.
Liang R; Khanna A; Muthusamy S; Li N; Sarojini H; Kopchick JJ; Masternak MM; Bartke A; Wang E
Aging Cell; 2011 Dec; 10(6):1080-8. PubMed ID: 21967153
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of Neural Precursor Cell Expressed Developmentally Downregulated 4-1 is Associated with Poor Prognosis and Chemoresistance in Lung Adenocarcinoma.
Song YH; Zhang CQ; Chen FF; Lin XY
Chin Med J (Engl); 2018 Jan; 131(1):16-24. PubMed ID: 29271375
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the quantitative balance between insulin-like growth factor (IGF)-1 ligand, receptor, and binding protein levels to predict cell sensitivity and therapeutic efficacy.
Tian D; Kreeger PK
BMC Syst Biol; 2014 Aug; 8():98. PubMed ID: 25115504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]